Apollo Hospitals, a leading pan-India hospital chain, is advancing plans for the Apollo HealthCo listing by the fourth quarter of the next financial year (Q4 FY27). This significant development emerges from a comprehensive, multi-layered restructuring initiative. Krishnan Akhileswaran, the group chief financial officer, has confirmed that the company is firmly on track to enable Apollo HealthCo to list as an independent entity by this target. The move represents a strategic effort to unlock greater shareholder value and foster robust synergies across its diverse healthcare businesses.
Strategic Restructuring and Apollo HealthCo Listing
During the second quarter of the current fiscal year, Apollo Hospitals successfully secured approval from the Competition Commission of India (CCI) for its extensive restructuring plan. This approval encompassed several key group entities, specifically Apollo HealthCo, Keimed, and Apollo Healthtech. The primary objective of this intricate reorganisation is to enhance operational focus and create distinct growth pathways for each segment. Therefore, the upcoming Apollo HealthCo listing is a direct outcome of these approved corporate actions, promising a clearer valuation for its digital and pharmacy businesses.
Moreover, Apollo Hospitals is embarking on a substantial expansion of its physical infrastructure. The chain aims to add approximately 3,650 operating beds over the next five years. This ambitious growth project requires a total investment of Rs 8,300 crore. Notably, this entire investment will be financed through internal accruals, demonstrating the company’s financial strength. Around 1,600 beds are projected for addition by the close of the next fiscal year, particularly in major metros and tier-1 cities such as Pune, Delhi, Kolkata, Gurgaon, Hyderabad, and Bengaluru. These expansions will involve a mix of greenfield and brownfield projects.
Financial Performance and Future Outlook
The company recently reported strong financial results for the September quarter, reflecting robust growth across its healthcare, diagnostics, and digital businesses. Consolidated revenue reached Rs 6,304 crore, marking a 13% year-on-year increase. Furthermore, earnings before interest, taxes, depreciation, and amortisation (EBITDA) grew by 15% to Rs 941 crore. Net profit for the second quarter saw an impressive 26% surge, totaling Rs 477 crore. For the first half of 2025-26, consolidated revenue increased by 14% year-on-year to Rs 12,146 crore, and net profit soared by 33% to Rs 910 crore. This strong performance underpins the company’s capability to fund its growth initiatives.
Healthcare services remain the largest revenue contributor, achieving a 9% year-on-year growth to Rs 3,169 crore. The retail healthcare and diagnostics arm, Apollo Health and Lifestyle Ltd, experienced a 17% increase in revenue, reaching Rs 474 crore. Importantly, the digital and pharmacy business, operating under Apollo HealthCo, posted a significant 17% growth, generating Rs 2,661 crore. Operationally, the hospital chain maintained a healthy occupancy rate of 69% during this period. The anticipated Apollo HealthCo listing is expected to further catalyse growth in these high-potential segments, attracting dedicated investor interest.
Frequently Asked Questions
Q1: What is the timeline for the Apollo HealthCo listing?
A1: Apollo Hospitals plans to list Apollo HealthCo by the fourth quarter of the next financial year (Q4 FY27), following a multi-layered restructuring plan.
Q2: How will Apollo Hospitals fund its planned bed capacity expansion?
A2: The entire investment of Rs 8,300 crore for adding 3,650 operating beds over the next five years will be funded exclusively through internal accruals.
Q3: What was the purpose of the restructuring approved by the Competition Commission of India?
A3: The restructuring, involving Apollo HealthCo, Keimed, and Apollo Healthtech, aims to unlock shareholder value, drive synergies, and provide distinct operational focus for each business segment.
References
- Apollo Hospitals eyes Q4 FY27 listing for HealthCo amid major restructuring – ETHealthworld
- Apollo Hospitals eyes Q4 FY26 listing for HealthCo amid major restructuring – Economic Times
- Competition Commission clears Apollo Hospital’s group entities restructuring plan – The Economic Times
- CCI Clears Apollo Hospitals’ Group Restructuring Plan – Digital Health News
- Apollo Hospitals Secures CCI Approval for Strategic Composite Scheme – ScanX
- CCI Approves Composite Scheme Involving Apollo Hospitals, Apollo Healthco, and Keimed – Live Law
- Apollo restructuring, CCI clearance boosts healthtech scale – Medical Buyer
- Apollo Hospitals Q2 Results: Net profit surges 26% YoY to ₹477 crore; revenue up 13% – Mint
- Apollo Hospitals to invest ₹8,000 crore, add 4,300 beds, boost presence in key cities – Fortune India
- Apollo Hospitals Share Price Jumps 3% as Board Approves Listing of Pharmacy & Digital Health Unit – Angel One
- Apollo Hospitals To Spin Off Pharmacy, Digital Health & Telehealth Into NEWCo, Set For Indian Stock Market Listing In 18-21 Months – Free Press Journal
- Demerger announcement: Apollo Hospitals to list digital & pharmacy biz in 18-21 months – The Economic Times
- Apollo Healthco Ltd (Investor Presentation) – Apollo Hospitals
- Apollo Healthtech targets listing by Jan-Mar 2027 – The Economic Times
- Apollo HealthCo to be ₹30,000 crore company in 5-6 yrs, says Shobana Kamineni – Live Mint
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.